Stock & Company Details
Citius Pharmaceuticals Inc $CTXR
Price:
N/A
N/A
27M
$13M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.19
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
CTXR technical indicators
Latest Citius Pharmaceuticals Inc (CTXR) indicator readings as of 2026-10-09.
CTXR's 14-day RSI is 39.3, in neutral territory. At $0.50 it is trading 27.4% below its 200-day moving average of $0.69, and below its 50-day average of $0.59. Price sits near the lower Bollinger Band ($0.48 to $0.62). ADX reads 19.9, indicating a range-bound market rather than a trend.
Overview
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, unique prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
Finance Bot
Ask your questions
Start by typing a question below.
